Virtual Library
Start Your Search
Xing Wang
Author of
-
+
EP1.18 - Treatment of Locoregional Disease - NSCLC (ID 208)
- Event: WCLC 2019
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
- Presentations: 1
- Now Available
- Moderators:
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.18-05 - Do We Have Better Choice for Inoperable Lung Cancer Patients with Good Performance Status? Concurrent Versus Sequential Chemo-Radiotherapy (Now Available) (ID 389)
08:00 - 18:00 | Author(s): Xing Wang
- Abstract
Background
Lung cancer has hitherto been the commonly life-threatening disease, adjuvant treatment regimens are being explored when tumors are beyond the indication of surgery. Concurrent chemo-radiotherapy is nowadays recommended when compared with sequential chemo-radiotherapy for overall survive benefits during treatment at the cost of increased acute esophageal toxicity.
Method
Studies are searched from the public database (PubMed, EMBASE, Medline, Cochrane library. Data were analyzed by calculating pooled hazard ratio(HR) for survival and dichotomous variables with risk ratio(RR) for toxicities. Survival benefits (OS and PFS) was regarded as primary outcome, and toxicities was the second outcome. Data consolidation was reflected through forest plots with the bias were evaluated through the tools of risks of bias.
Result
8 studies contained 1223 patients were finally included in this meta-analysis. There were no significant benefits in concurrent chemo-radiotherapy on the two groups’ overall survival (HR,0.92; 95% CI, 0.81 to 1.04; p=0.18). Concurrent chemo-radiotherapy performed better in progression-free survival comparing with sequential chemo-radiotherapy (HR,0.83; 95% CI, 0.73 to 0.95; p=0.007). Concurrent chemo-radiotherapy increase the esophagitis and thrombocytopenia (grade 3-4), with (RR 4.49; 95% CI, 3.18 to 6.33; p<0.0001) and (RR 1.55; 95% CI,1.01 to 2.39; p=0.04), respectively. Whereas the two groups performed little significant difference in pulmonary toxicities (RR 0.83; 95% CI, 0.64 to 1.08; p=0.18).
Conclusion
8 studies contained 1223 patients were finally included in this meta-analysis. There were no significant benefits in concurrent chemo-radiotherapy on the two groups’ overall survival (HR,0.92; 95% CI, 0.81 to 1.04; p=0.18). Concurrent chemo-radiotherapy performed better in progression-free survival comparing with sequential chemo-radiotherapy (HR,0.83; 95% CI, 0.73 to 0.95; p=0.007). Concurrent chemo-radiotherapy increase the esophagitis and thrombocytopenia (grade 3-4), with (RR 4.49; 95% CI, 3.18 to 6.33; p<0.0001) and (RR 1.55; 95% CI,1.01 to 2.39; p=0.04), respectively. Whereas the two groups performed little significant difference in pulmonary toxicities (RR 0.83; 95% CI, 0.64 to 1.08; p=0.18).
-
+
MA10 - Emerging Technologies for Lung Cancer Detection (ID 129)
- Event: WCLC 2019
- Type: Mini Oral Session
- Track: Screening and Early Detection
- Presentations: 1
- Now Available
- Moderators:Fabrizio Bianchi, Marcelo Sanchez
- Coordinates: 9/08/2019, 15:15 - 16:45, Dublin (1997)
-
+
MA10.02 - Deep Learning with Radiomics May Predict High-Grade Lung Adenocarcinoma Based on Histological Patterns in Ground Glass Opacity Lesions (Now Available) (ID 128)
15:15 - 16:45 | Presenting Author(s): Xing Wang
- Abstract
- Presentation
Background
Adenocarcinoma (ADC) is the most common histological subtype of lung cancers in non small cell lung cancer (NSCLC) in which ground glass opacifications (GGOs) found on computed tomography (CT) scans are the most common lesions. These lesions are usually treated with limited lung resection. However, the presence of a micropapillary or solid component is identified as an independent predictor of prognosis, indicating a more extensive resection. The accurate classification of subtypes still remains difficult in radiology or in frozen pathological analysis, even with the help of classical radiomics. The purpose of our study is to explore imaging phenotyping using a novel method combining radiomics with deep learning (RDL) to predict high-grade patterns within lung ADC.
Method
Included in this study were 111 patients differentiated as having GGOs and pathologically confirmed ADC. Four different methods were compared to classify the GGOs for the prediction of the pathological subtypes of high-grade lung ADCs, including classic machine learning, radiomics, deep learning method, and a proposed novel method referred as RDL. A four-fold cross-validation approach was used to evaluate the performance of such methods.
Result
We analyzed 32 patients with high-grade patterns and 79 without such patterns. The proposed RDL has achieved an overall accuracy of 0.888, which significantly outperforms classic machine learning, radiomics, and deep learning alone (p< 0.001, paired t-test).
Conclusion
High-grade lung ADC based on histologic pattern spectrum in GGO lesions might be predicted by a novel framework combining radiomics with deep learning, which reveals a significant advantage over traditional methods.
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
-
+
OA10 - Sophisticated TNM Staging System for Lung Cancer (ID 136)
- Event: WCLC 2019
- Type: Oral Session
- Track: Staging
- Presentations: 1
- Now Available
- Moderators:Ke-Neng Chen, Pedro Lopez De Castro
- Coordinates: 9/09/2019, 14:00 - 15:30, Toronto (1985)
-
+
OA10.06 - Transition Patterns Between N1 and N2 Stations Discovered from Data-Driven Lymphatic Metastasis Study in Non-Small Cell Lung Cancer (Now Available) (ID 1499)
14:00 - 15:30 | Presenting Author(s): Xing Wang
- Abstract
- Presentation
Background
N staging process was essential for evaluation of outcome and indication of following adjuvant therapies in Non-small-cell lung cancer treatment. Various clinical observations on the potential transition patterns of lymph node drainage are reported, however, most of the previous conclusions were made by clinical physicians and focused on specific empirical transition patterns. The fact that there is no definitive and holistic map for lymphatic metastasis transition patterns, and the patients were suffering from either excessive nodes collection along with more damage, or insufficient nodes collection with potential recurrent risks.
Method
We perform complete lymph node examination of a total of 936 subjects diagnosed with NSCLC lung cancer. Lymph nodes sampling or dissection are performed according to NCCN guidelines.
A probabilistic model is developed due to the presence of these missing values. Using the maximum likelihood estimation and proximal gradient algorithm, the summarization of dataset is obtained, which were several explicit metastases and their corresponding probabilities. The metastasis graph is constructed from the summarization result with greedy algorithm and a given threshold. Besides, numerical simulation experiments are conducted to validate the stability of algorithms.
Result
Lymph node sites are shown as round circles according to their anatomical locations. The inferred transition paths are shown as edges connecting them. Edges colored in red are those consistently found in the left and right lung, and blue for unique nodes at each side thus cannot be compared, and black for different patterns between left and right lungs.
Closely connected intra-lobar (N1) nodes: strong connections among intra-lobar nodes (10~14). Over 78% among all the patients have more than 7 edges connecting the 5 intra-lobar nodes.
Jumping metastasis from N1 to N2 stations: We found that there exists several jumping metastasis at both sides of the lobes which has not been well-studied yet posing a challenge for the diagnosis and accurate staging (eg. 12 to 4, 13 to7, 11 to 2), revealing potential long-range transition pathways.
Correlation among N2 lymph nodes: We discovered the presence of certain metastatic groups, including node 5/6, 5/9, 7/9, 6/8 for left lung, and 2/4,2/7,7/9, 2/3p, 3p/7 for right lung.
Conclusion
So we drew a map precisely to make a better understanding for metastatic pathways and provide a potential tool for the prediction of involved nodes pre/ or intro-operatively,so that an individualized surgical planning strategy could be made.
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.